Healthcare provider profile · identity verified

Jon T Peterson, DO

Family Practice · ANACORTES, WA · NPI 1669553723

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	331	100
Levothyroxine Sodium	Levothyroxine Sodium	276	78
Lisinopril	Lisinopril	259	80
Tamsulosin Hcl	Tamsulosin Hcl	230	78
Losartan Potassium	Losartan Potassium	208	62
Amlodipine Besylate	Amlodipine Besylate	200	63
Trazodone Hcl	Trazodone Hcl	135	37
Hydrochlorothiazide	Hydrochlorothiazide	128	36
Metformin Hcl	Metformin Hcl	124	37
Omeprazole	Omeprazole	117	39
Metoprolol Succinate	Metoprolol Succinate	115	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	110	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	102	14
Gabapentin	Gabapentin	96	28
Rosuvastatin Calcium	Rosuvastatin Calcium	94	31
Albuterol Sulfate Hfa	Albuterol Sulfate	91	36
Simvastatin	Simvastatin	89	29
Jardiance	Empagliflozin	78	20
Pravastatin Sodium	Pravastatin Sodium	77	26
Allopurinol	Allopurinol	71	23
Lorazepam	Lorazepam	71	20
Furosemide	Furosemide	70	23
Eliquis	Apixaban	69	21
Alprazolam	Alprazolam	67	15
Oxycodone Hcl	Oxycodone Hcl	65	11
Ozempic	Semaglutide	61	suppressed
Clonazepam	Clonazepam	60	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	58	18
Sertraline Hcl	Sertraline Hcl	55	16
Clopidogrel	Clopidogrel Bisulfate	54	18
Metoprolol Tartrate	Metoprolol Tartrate	54	15
Tramadol Hcl	Tramadol Hcl	54	13
Zolpidem Tartrate	Zolpidem Tartrate	51	13
Diazepam	Diazepam	48	suppressed
Lovastatin	Lovastatin	48	15
Montelukast Sodium	Montelukast Sodium	46	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	15
Finasteride	Finasteride	42	17
Hydroxyzine Hcl	Hydroxyzine Hcl	40	suppressed
Atenolol	Atenolol	39	12
Celecoxib	Celecoxib	36	suppressed
Potassium Chloride	Potassium Chloride	36	13
Ibuprofen	Ibuprofen	35	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	12
Meloxicam	Meloxicam	34	14
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	11
Spironolactone	Spironolactone	33	suppressed
Fluticasone Propionate	Fluticasone Propionate	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Prednisone	Prednisone	31	17
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Clonidine Hcl	Clonidine Hcl	28	suppressed
Estradiol	Estradiol	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Methocarbamol	Methocarbamol	27	suppressed
Nitroglycerin	Nitroglycerin	27	14
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Temazepam	Temazepam	27	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	27	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	11
Bupropion Xl	Bupropion Hcl	25	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Amoxicillin	Amoxicillin	23	suppressed
Azithromycin	Azithromycin	23	12
Buspirone Hcl	Buspirone Hcl	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Morphine Sulfate Er	Morphine Sulfate	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Glipizide Er	Glipizide	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Carvedilol	Carvedilol	18	suppressed
Famotidine	Famotidine	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	11
Hydromorphone Hcl	Hydromorphone Hcl	16	suppressed
Cephalexin	Cephalexin	15	11
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Propranolol Hcl	Propranolol Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	14
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Torsemide	Torsemide	14	suppressed
Dulera	Mometasone/Formoterol	13	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Colchicine	Colchicine	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Nystatin	Nystatin	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Risperidone	Risperidone	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Diclofenac Potassium	Diclofenac Potassium	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Naproxen	Naproxen	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Trintellix	Vortioxetine Hydrobromide	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error